Pascal Turlure
Université d'Orléans(FR)Institut de Cancérologie Strasbourg(FR)XLIM(FR)Centre Hospitalier Universitaire de Limoges(FR)Centre Hospitalier Universitaire de Clermont-Ferrand(FR)Centre hospitalier universitaire d'Orléans(FR)Hôpital Dupuytren(FR)Hôpital Civil, Strasbourg(FR)Université de Limoges(FR)Université de Strasbourg(FR)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, Hematopoietic Stem Cell Transplantation, Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study(2012)979 cited
- → Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera(2008)567 cited
- → Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine(2010)384 cited
- → Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial(2018)340 cited
- → High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group(2006)284 cited
- →